Keynote Presentation

Total Page:16

File Type:pdf, Size:1020Kb

Keynote Presentation The Massachusetts Life Sciences Center Return on Investment September 29, 2010 0 The Massachusetts Life Sciences Initiative – Major objectives State investments in the life sciences “Super Cluster”: Promote economic development Support the Commonwealth’s world-class academic medical centers, research institutions, universities and industry leaders Promote a highly skilled and educated workforce Create an industry-friendly environment Strengthen and protect Massachusetts’ global leadership position in the Life Sciences Support the development of treatments, therapies and cures 1 The Massachusetts Life Sciences Center – Board of Directors Secretary of Housing and Economic Development ¾ Gregory Bialecki Secretary of Administration and Finance ¾ Jay Gonzalez President of the University of Massachusetts System ¾ Jack Wilson, Ph.D. A CEO of a Massachusetts-based life sciences corporation ¾ Abbie Celniker, CEO, Taligen Therapeutics A researcher involved in the commercialization of biotechnology, pharmaceuticals or medical diagnostic products ¾ Lydia Villa-Komaroff, Board Member and CSO, Cytonome/ST A physician licensed to practice medicine in the Commonwealth and affiliated with an academic medical center ¾ Peter Slavin, M.D., President, Massachusetts General Hospital A person with financial expertise in the life sciences ¾ Joshua Boger, Ph.D., Former President & CEO, Vertex 2 Massachusetts Life Sciences Center Scientific Advisory Board • CHAIR: Harvey Lodish, Ph.D., Whitehead • Richard A. Goldsby, Ph.D., John Woodruff Institute, and Professor of Biology and of Simpson Lecturer and Professor of Biology, Amherst Bioengineering, MIT College • James Barry, Ph.D., Vice President, Corporate • Jeffrey Leiden, M.D., Ph.D., Managing Director, Research and Advanced Technology Development, Clarus Ventures Boston Scientific • David T. Scadden, M.D., Professor of Medicine, • Doug Cole, M.D., General Partner, Flagship Ventures Harvard University, Co-Chair, Department of Stem Cell and Regenerative Biology, Harvard University, • James J. Collins, Ph.D., Professor of Biomedical Co-Director, Harvard Stem Cell Institute, Director, Engineering, Boston University MGH Center for Regenerative Medicine • George Q. Daley, M.D., Ph.D., Children's Hospital • Alan E. Smith, Ph.D., Chief Scientific Officer, Boston, Harvard Medical School, Harvard Stem Cell Genzyme Corp. Institute • Allison Taunton-Rigby, Ph.D., CEO and Director, • Patricia K. Donahoe, M.D., Director of the Pediatric Surgical Research Laboratories and Chief RiboNovix, Inc. Emerita of Pediatric Surgical Services at Massachusetts General Hospital, and the Marshall •David Walt, Ph.D., Robinson Professor of K. Bartlett Professor of Surgery at the Harvard Chemistry and Howard Hughes Medical Institute Medical School Professor at Tufts University School of Medicine. • Jonathan Fleming, M.P.A., Managing General •Philip Zamore, Ph.D., Professor, Biochemistry and Partner, Oxford Bioscience Partners Molecular Pharmacology, UMass Medical School • Jean M. George, M.B.A., Partner, Advanced Technology Ventures • Lila Gierasch, Ph.D., Professor of Biophysical Chemistry, Department of Biochemistry, University of Massachusetts Amherst 3 MLSC Strategy Summary: Priorities and Focus Areas Strategic priorities: Vision 9 Competitiveness of the State’s academic institutions 9 Pipeline of new therapies, technologies, Mission molecules, etc 9 Supply and distribution of life sciences workers with skills that are aligned with Strategic Priorities stakeholder needs 9 LS infrastructure and ecosystem 9 Retention and growth of LS companies Focus areas for investment: 9 Competitiveness: Faculty grants and infrastructure Focus Areas 9 Pipeline: Industry sponsored (translational) research; New Investigators, and Young Companies Programs, Products, Services 9 Workforce: Entry level workers; New Investigators Impact 9 Infrastructure: Capital Projects 9 Retention and Investment: Tax Incentives 4 Life Sciences Initiative Investment Tools d FY 10 = $30M n T FY 10 = $25M a u x F $ l In 2 FY 11 = $TBD ta c 5 FY 11 = $25M i e 0 p n m a t C iv il e li • 10 years on ion P l r il • $1 billion o g m r 0 Investment a 0 m 5 $ $250m Investment Fund (subject to appropriation) FY 10 = $10M FY 11 = $10M 5 The “Bottom Line” Life Sciences Center’s Impact: June ‘08 – July ‘10 Matching Investments Attracted = $706 M Job Potential = 6,501 • Corporate Investors • Permanent Public Dollars Invested • NIH = $191.5 M 4 X multiplier • Private Foundations Grants to Academic Organizations and • Institutes • Building Trades Medical Centers • Other Private Investors “Shovel Ready” Capital Projects • Academic Institutions Life Sciences Companies 6 Center Programming Portfolio Funding Gap Framework & Programming at a Glance Universities,Universities, Current programs help Institutes, Institutes, Companies late stage companies MedicalMedical Companies CentersCenters Patent Filing Launch 1250 Discovery Development 1000 Initial R&D Preclinical Phase I Phase II Phase III FDA/510k Product/prototype Review 750 Discovery, Approval identification Public Equities 500 Corporate & Debt Grants Venture Venture Mezzanine and Funding Funding Financing (in millions) 250 Angels Public Equities &IPO Time in Market Annual Net Cash Flow 0 Funding Gap Funding Gap Highest Risk Medium Risk Medium Risk Lowest Risk & Lowest & Low or & Medium & Highest -250 Valuation Medium Valuation Valuation Valuation -500 Accelerator Bonded Capital Fund Small Business Fund Tax Incentive Bonded Capital Fund Cooperative Research 7 Investment Fund Programs Investments in Scientific Research: Matching Grant Program 2008: the MLSC launches a Matching Grant Program for new investigators, faculty positions, and cooperative research in Massachusetts. These grants: Are enabling 21 young Massachusetts scientists to continue their research, establish independent laboratories and possibly secure larger-scale NIH funding Are improving the ability of five (5) universities and academic medical centers across Massachusetts to compete more effectively for top faculty Are funding research collaborations between six (6) industry and academic partners focused on new therapies and The Center’s grants leveraged $12.6 technologies with high commercialization million in matching funds from private potential and public research institutions and Will accelerate the translation of industry sponsors -- creating a $25.2 treatments and therapies “from the research million investment in translational bench to the bedside” research across the Commonwealth 8 Investment Fund Programs Leverage on the New Investigator Grant Program* To date, nearly half (43%) of the Center’s New Investigators (9 of 21) have leveraged their MLSC grants with follow-on funding. The Center’s investment in these nine (9) Investigators totals $2.4M. However, these nine (9) New Investigators have won 15 grants totaling over $6.5M. Leverage on MLSC investment = 2.7x *A total of 21 New Investigators were funded; MLSC grants average $100k for 2-3 years; all grants received a 1:1 match from the Investigator’s affiliated academic institution 9 Investment Fund Programs New Investigators’ Scientific Contributions* In addition, over half (57%) of the Center’s New Investigators (12 of 21) have published articles based on the work being funded by MSLC grants. These 12 grantees have published a combined total of 31 articles that have been presented in the following journals: ¾ Applied Physics ¾ Nature ¾ Cell ¾ Nature Biotechnology ¾ EMBO Journal ¾ Nature Methods ¾ European Journal of Immunology ¾ Nature Reviews Immunology ¾ Gastroenterology ¾ New England Journal of Medicine ¾ Genes & Development ¾ Optics Express ¾ Hearing Research ¾ Proceedings of the National ¾ Journal of Bacteriology Academy of Sciences ¾ National Academy of Science ¾ Sem. Immunology *A total of 21 New Investigators were funded; MLSC grants average $100k for 2-3 years; all grants received a 1:1 match from the Investigator’s affiliated academic institution 10 Investment Fund Programs Matching Research Grants -- Cooperative Research Grants The Cooperative Research Grants encourage industry-sponsored research at Massachusetts academic institutions and accelerate “bench to bedside.” The Center awarded 6 grants totaling $3.76 million. Research Partners Award Recipient Award Research UMass Lowell/ $199,596 per year Novel polymer Dr. Rudolf Faust Boston Scientific for three years biomaterials Immune Disease Institute/ Epic $250,000 per year An siRNA-based Dr. Judy Lieberman Therapeutics for three years microbicide Harvard School of Engineering and Development of a $250,000 per year Applied Sciences/ Dr. David Weitz functional fluorescent- for three years Rain Dance Technologies activated cell sorter Massachusetts General Hospital/ $63,100 per year Targeting of toll-like Dr. Andrew Luster Idera Pharmaceuticals for three years receptors in A.I.D. Design and testing Brigham & Women’s Hospital/ Dr. Richard Lee $250,000 per year of a new regenerative Biomeasure Dr. Prath Patwari for three years protein for delivery Development of UMass Medical School/ Dr. Michael Czech $249,593 per year orally-delivered RNAi Rxi Pharmeceuticals Dr. Gary Ostroff for three years therapeutics 11 Investment Fund Programs Focused Initiatives: Regenerative Medicine The Center is funding resource centers to help Massachusetts grow and retain leadership in high innovation segments – such as regenerative medicine. 2008: The Center invests $570,000 in the International Stem Cell Registry and $7.7 million in the
Recommended publications
  • BLUE HEN CHEMIST University of Delaware, Department of Chemistry and Biochemistry Annual Alumni Newsletter Number 41 August 2014 John L
    BLUE HEN CHEMIST University of Delaware, Department of Chemistry and Biochemistry Annual Alumni Newsletter NUMBER 41 AUGUST 2014 JOHN L. BURMEISTER, EDITOR ON THE COVER THREE Newly Renovated Organic Laboratories! # 3 8 - P AGE I BLU E H E N C H E MIST ON THE COVER One of the three newly-renovated Organic Chemistry teaching laboratories (QDH 302) is shown. Work on the labs (QDH 112, 318, 320) started on May, 2013 and was completed in February of this year. The refurbishment of the labs was a crucial step in the ongoing revision of the Organic Chemistry laboratory curricula. The additional fume hoods allow each student to conduct experiments individually while minimizing their exposure to chemical reagents. The transparent glass construction helps teaching assistants observe students while they work. The hoods are equipped with inert-gas lines, which can allow the students to work with air-sensitive compounds and learn advanced laboratory techniques. The hoods are also equipped with vacuum lines, which obviate the need for water aspirators and dramatically reduce the labs' water usage. The lab design also allows for instrumentation modules to be swapped in and out according to the needs of the experiment. Carts are designed to house instruments such as gas chromatographs and infrared spectrometers as well as any necessary computer equipment. These carts can then be wheeled into docking areas that have been fitted with the necessary inert gas and electrical lines. The design expands the range of possible instrumentation the students can use while occupying a small footprint of lab space. The labs also feature large flat screen monitors, wireless internet, and computer connectivitiy that will enable the use of multimedia demonstrations and tablet computing.
    [Show full text]
  • Physicochemical Properties of Cells and Their Eects on Intrinsically Disordered Proteins (Idps)
    Review pubs.acs.org/CR Open Access on 06/05/2015 Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs) Francois-Xavier Theillet,†,∇ Andres Binolfi,†,∇ Tamara Frembgen-Kesner,‡ Karan Hingorani,§ Mohona Sarkar,∥ Ciara Kyne,⊥ Conggang Li,# Peter B. Crowley,⊥ Lila Gierasch,§ Gary J. Pielak,∥ Adrian H. Elcock,‡ Anne Gershenson,§ and Philipp Selenko*,† †Department of NMR supported Structural Biology, In cell NMR Laboratory, Leibniz Institute of Molecular Pharmacology (FMP Berlin), Robert Roessle Strasse 10, 13125 Berlin, Germany ‡Department of Biochemistry, University of Iowa, Bowen Science Building, 51 Newton Road, Iowa City, Iowa 52242, United States §Departments of Biochemistry & Molecular Biology and Chemistry, Program in Molecular & Cellular Biology, University of Massachusetts, Amherst, 240 Thatcher Way, Amherst, Massachusetts 01003, United States ∥Department of Chemistry, Department of Biochemistry and Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina 27599 3290, United States ⊥School of Chemistry, National University of Ireland, Galway, University Road, Galway, Ireland #Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences, Wuhan, 430071, P.R. China 3.2.2. Alternative Splicing 6673 3.2.3. Proteolytic Processing 6673 3.3. Intracellular IDP Stability and Degradation 6673 3.4. Factors Affecting Intracellular IDP Degrada- tion 6675 3.5. Molecular Chaperones 6675 3.5.1. Disordered Chaperones 6676 3.5.2. Disordered Chaperone Substrates 6676 3.6. IDPs and Post-Translational Modifications (PTMs) 6676 3.6.1. IDPs as PTM Targets 6677 CONTENTS 3.6.2.
    [Show full text]
  • Annual Symposium Program
    rd 33 Annual Symposium Program June 30 - July 3, 2019 www.proteinsociety.org Table of Contents 2 Welcome 3 Program Planning Committee Mission 4 Committees The Protein Society is a not-for-profi t scholarly society 7 Corporate Support with a mission to advance state-of-the-art science through international forums that promote commu- 8 Registration nication, cooperation, and collaboration among scientists involved in the study of proteins. 9 Hotel Floor Plan For 33 years, The Protein Society has served as the in- 11 Posters tellectual home of investigators across all disciplines - and from around the world - involved in the study 12 General Information of protein structure, function, and design. The Soci- ety provides forums for scientifi c collaboration and 16 2019 Protein Society Award Winners communication and supports professional growth of young investigators through workshops, networking 22 Travel Awards opportunities, and by encouraging junior research- ers to participate fully in the Annual Symposium. In 24 At-A-Glance addition to our Symposium, the Society’s prestigious journal, Protein Science, serves as an ideal platform 28 Program to further the science of proteins in the broadest sense possible. 42 Exhibitor List and Directory 52 Poster Presentation Schedule 66 Abstracts: TPS Award Winners & Invited Speakers #PS33 90 Posters 1986 - 2019 1 Welcome Program Planning Committee Welcome to Seattle and to the 2019 33rd Annual Sym- posium of the Protein Society! Seattle | June 30 - July 3, 2019 We are excited to bring you this year’s Annual Sym- posium comprising 12 exceptional scientifi c sessions that cover a wide range of scientifi c achievement in the fi eld of protein science, as well as a Nobel Laureate Lecture from 2017 Chemistry Nobel Laure- ate Richard Henderson.
    [Show full text]
  • Women Physiologists
    Women physiologists: Centenary celebrations and beyond physiologists: celebrations Centenary Women Hodgkin Huxley House 30 Farringdon Lane London EC1R 3AW T +44 (0)20 7269 5718 www.physoc.org • journals.physoc.org Women physiologists: Centenary celebrations and beyond Edited by Susan Wray and Tilli Tansey Forewords by Dame Julia Higgins DBE FRS FREng and Baroness Susan Greenfield CBE HonFRCP Published in 2015 by The Physiological Society At Hodgkin Huxley House, 30 Farringdon Lane, London EC1R 3AW Copyright © 2015 The Physiological Society Foreword copyright © 2015 by Dame Julia Higgins Foreword copyright © 2015 by Baroness Susan Greenfield All rights reserved ISBN 978-0-9933410-0-7 Contents Foreword 6 Centenary celebrations Women in physiology: Centenary celebrations and beyond 8 The landscape for women 25 years on 12 "To dine with ladies smelling of dog"? A brief history of women and The Physiological Society 16 Obituaries Alison Brading (1939-2011) 34 Gertrude Falk (1925-2008) 37 Marianne Fillenz (1924-2012) 39 Olga Hudlická (1926-2014) 42 Shelagh Morrissey (1916-1990) 46 Anne Warner (1940–2012) 48 Maureen Young (1915-2013) 51 Women physiologists Frances Mary Ashcroft 56 Heidi de Wet 58 Susan D Brain 60 Aisah A Aubdool 62 Andrea H. Brand 64 Irene Miguel-Aliaga 66 Barbara Casadei 68 Svetlana Reilly 70 Shamshad Cockcroft 72 Kathryn Garner 74 Dame Kay Davies 76 Lisa Heather 78 Annette Dolphin 80 Claudia Bauer 82 Kim Dora 84 Pooneh Bagher 86 Maria Fitzgerald 88 Stephanie Koch 90 Abigail L. Fowden 92 Amanda Sferruzzi-Perri 94 Christine Holt 96 Paloma T. Gonzalez-Bellido 98 Anne King 100 Ilona Obara 102 Bridget Lumb 104 Emma C Hart 106 Margaret (Mandy) R MacLean 108 Kirsty Mair 110 Eleanor A.
    [Show full text]
  • Biophysicist in Profile
    Biophysicist in Profile explains, “where the professors let you know that anything is possible, that you 9650 Rockville Pike can do anything.” Bethesda, Maryland 20814-3998 Tel: 301-530-7114; Fax: 301-530-7133 In her sophomore year cell biology E-mail: [email protected] http://www.biophysics.org/ class, while listening to her professor, Officers Kay Eschenberg, Gierasch recalls think- President ing to herself, “I want to do this!” She Wilma K. Olson enjoyed exploring questions about bio- President-Elect Yale Goldman logical systems with a chemical perspec- Past-President tive, and her senior thesis was on the Mary Dicky Barkley refolding of collagen single chains into Secretary Jill Trewhella triple helical molecules. She recalls her Treasurer lab time in college fondly, thrilled to Antonio Scarpa spend time “playing in her sand box.” Council Dorothy Beckett During the summer following her Diana J. Bigelow Lila Gierasch junior year while working at Harvard in Mordecai P. Blaustein the lab of Alwyn Pappenheimer, she saw Robert Clegg Franco Conti Lila Gierasch credits being in the right a poster for the International Union of Timothy A. Cross place at the right time with much of her Biophysics Congress at MIT and attend- Cristobal G. Dos Remedios success. It also helps that she has bound- ed it. “There, I listened to the founding Edward H. Egelman Julio Fernandez less energy and determina- fathers of bio- Jeff Gelles tion and knows what she She recalls her lab time in physics speak,” Susan L. Hamilton wants. Born in Needham, James M. Hogle college fondly, as time spent she remembers, Linda Kenney Massachusetts, Gierasch “playing in her sand box.” “and getting the James C.
    [Show full text]
  • Personalized Protocols
    Vol. 18 / No. 6 / June/July 2019 THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY PERSONALIZED PROTOCOLS Mental health accommodations can help some succeed in the lab — but fi rst they have to ask JBC REVIEWS.pdf 1 2/22/19 4:12 PM JBC REVIEWS Stimulating analyses defining new directions in science Save yourself from a landslide of literature. Read JBC Reviews to get expert insights into recent findings, C ongoing controversies and unsolved M Y questions in biological chemistry. CM MY CY CMY K Download for free at jbc.org. CONTENTS NEWS FEATURES PERSPECTIVES 2 26 44 EDITOR’S NOTE PERSONALIZED PROTOCOLS RESEARCH SPOTLIGHT Magazine life Mental health accommodations can e link between metabolism and aging help some succeed in the lab — 3 but rst they have to ask 46 NEWS FROM THE HILL ESSAY Advocating for more than money 34 Mental illness should not disqualify me 4 LISTENING TO KETAMINE 48 MEMBER UPDATE ESSAY 7 What I wish people understood about ... NEW MEMBERS 50 OUTREACH 10 University program inspires future scientists HONOR SOCIETY INDUCTEES 54 11 ANNUAL MEETING BIOCHEM, WITH A SIDE 26 Scenes from Orlando OF ADVOCACY 12 LIPID NEWS An ever-growing role for a tiny lipid 14 JOURNAL NEWS 14 Out tting T cell receptors for special combat 16 How do protein tangles get so long? 17 Cascading errors 44 50 18 Study shows long-term e ects of weight loss on the proteome 19 From the journals 24 A YEAR OF BIO(CHEMICAL) ELEMENTS Atomic Nos. 6 and 7 34 JUNE/JULY 2019 ASBMB TODAY 1 EDITOR’S NOTE THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY Magazine life OFFICERS COUNCIL MEMBERS Gerald Hart Squire J.
    [Show full text]
  • American Society for Biochemistry and Molecular Biology
    Vol. 12 No. 7 August 2013 American Society for Biochemistry and Molecular Biology contents AUGUST 2013 On the cover: In this issue, we offer news, news advice and perspectives about various aspects of work 3 President’s Message and school. 27 Imagining a sustainable biomedical enterprise 5 News from the Hill Turning controversy into action 6 Member Update 8 Annual award winners 9 Retrospectives 9 François Jacob (1920 – 2013) 11 Adolphus P. Toliver (1931 – 2013) This month’s contribution to our essay series is by Harvey “Jim” Armbrecht, who writes about his wife’s diagnosis of Lewy features body disease and about the SAMP8 mouse, a model for early memory loss. 14 18 Virginia Lee: notes on a career 24 Venom-based therapies departments INSIDE THE BROWN BAG 44 Outreach ISSUE Rap Genius 28 Going M.D./Ph.D. vs. going 100% Ph.D. 46 Journal News 29 The evolution of biomedical science and you 46 JBC: A deeper look into cholesterol synthesis 30 Plenty of options for students with all degrees of interest in research and medicine 47 JBC: Potent antifreeze protein’s structure determined 31 A blog, a CV and a domain name 47 JBC: James E. Darnell’s “Reections” 32 Crafting an online presence 35 How to nd the right lab rotation 49 JBC: Recent ndings on presenilins and signal peptide peptidase 35 How to broach the funding issue with prospective PIs 49 JLR: Thematic series on fat-soluble vitamins 37 Choosing the right journal for your work 50 MCP: Protein quantication: by mass 39 The brains behind Coursera’s spectrometry or Western blotting? neuroscience offering 42 AARP’s annual ranking of workplaces for 51 Career Insights employees over 50 Lessons learned: notes on becoming an educator outside of academia 53 Mentoring Taking a holistic view 56 Lipid News N Fer! Coenzyme A: when small is mighty POINT / COUNTERPOINT Eleftherios P.
    [Show full text]
  • ASBMB Today Wins Awards Nicholas O
    Vol. 19 / No. 8 / September 2020 A zest FOR synthetic biology The 2021 ASBMB Annual Meeting will be virtual! Learn more at asbmb.org/annual-meeting The ASBMB annual meeting is held in conjunction with Experimental Biology. CONTENTS NEWS FEATURES PERSPECTIVES 2 24 40 EDITOR’S NOTE A ZEST FOR SYNTHETIC BIOLOGY THE COVID-19 DELUGE A time for reimagining Why are metabolic engineers so interested Is it time for a new model of data disclosure? in limonene? 3 43 NEWS 32 THE TIME FOR CHANGE IS NOW Society to name fellows RUNNING A JOURNAL IN A PANDEMIC ASBMB Today wins awards Nicholas O. Davidson and Kerry-Anne Rye talk about editing the Journal of Lipid 44 4 Research across a staggering distance THE MIND OF A PUBLIC SPEAKER MEMBER UPDATE 36 MEET LUKE O’NEILL 48 7 The immunologist shares his thoughts SUMMER UNDERGRADUATE IN MEMORIAM on inflammation research and the novel RESEARCH WEATHERS THE 8 Herbert Tabor (1918-2020) coronavirus PANDEMIC 10 COVER PHOTO: OKEYKAT/ UNSPLASH 52 RESEARCH SPOTLIGHT ON MANAGING AND MENTORING A career in metabolism research and a drive to mentor minority students 5 questions for Jenna Hendershot 13 STUDENT CHAPTERS Science and medicine: Connecting the known and the unknown 24 15 JOURNAL NEWS 15 A disorder of disrupted proteins 16 Spit-stimulating natural compounds could end dry mouth 17 Health journey helps researcher teach old mice new tricks 44 18 From the journals 32 10 36 48 SEPTEMBER 2020 ASBMB TODAY 1 EDITOR’S NOTE THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY THE MEMBEROFFICERS MAGAZINE OFCOUNCIL THE AMERICAN MEMBERS SOCIETY A time for reimagining FOR BIOCHEMISTRY ANDSuzanne MOLECULAR Barbour BIOLOGY Toni M.
    [Show full text]
  • March 2018 Asbmb Today 1 Editor’S Note
    CONTENTS NEWS FEATURES PERSPECTIVES 2 18 48 EDITOR’S NOTE MYALGIC ENCEPHALOMYELITIS: RESEARCH SPOTLIGHT Not crying wolf UNKNOWN CAUSE. A love of teaching and the chemistry of living organisms 3 NO CURE. NEW HOPE NEWS FROM THE HILL 32 50 Appropriations season — FROM A BAVARIAN BACCALAUREATE OUTREACH what we want and how to help TO BACTERIAL BLEACH Sparking the flame of science 4 36 52 NEWS ESSAY Member update 2018 TABOR AWARD WINNERS Leadership: the sock’s-eye view 9 44 WHAT TO WEAR 54 LIPID NEWS WHEN SCIENCE MEETS SICKNESS The state of the lipid research community — AT THE ANNUAL MEETING improving grant review Science prepared me for cancer treatments, but nothing prepared me for surviving 10 JOURNAL NEWS 18 52 10 miRNAs take the wrecking ball to colorectal cancer 12 When HIV drugs don’t cooperate 13 A rare blood disease can teach us about blood clotting 14 Charting the mitochondrial interactome 15 From the journals 12 15 54 WHEN SCIENCE MEETS SICKNESS MARCH 2018 ASBMB TODAY 1 EDITOR’S NOTE THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY Not crying wolf By Comfort Dorn OFFICERS COUNCIL MEMBERS Natalie Ahn Squire J. Booker President Victoria J. DeRose Wayne Fairbrother ave you ever felt sick enough ovary syndrome — and the subject of Gerald Hart Rachel Green President Elect Blake Hill that you thought you should this month’s cover story: the almost see a doctor — made an unpronounceable myalgic Jennifer DuBois Susan Marqusee H Secretary Celia A. Shiffer appointment, took time off work, encephalomyelitis. Takita Felder Sumter hired a babysitter, spent an hour As Lily Williams reminds us in her Toni M.
    [Show full text]
  • Massachusetts Life Sciences Center FY 2011 Annual Report
    Massachusetts Life Sciences Center FY 2011 Annual Report Delivering on the Promise To: Governor Deval Patrick Secretary of Administration and Finance Jay Gonzalez Senate President Therese Murray Speaker of the House Robert DeLeo State Comptroller Martin Benison Clerk of the Senate William Welch Clerk of the House of Representatives Steven James By forward: House and Senate Committees on Ways and Means and the Joint Committee on Economic Development and Emerging Technologies From: Susan Windham-Bannister, Ph.D. Date: September 30th, 2011 Re: Fiscal Year 2011 Annual Report of the Massachusetts Life Sciences Center _____________________________________________________________________________ The Massachusetts Life Sciences Center (the “Center”) respectfully submits this Annual Report detailing our operations and accomplishments during Fiscal Year 2011. We are the hub of the Commonwealth’s thriving life sciences Supercluster and proudly serve as stewards of the $1 billion Massachusetts Life Sciences Initiative, which was passed by the Legislature and signed into law in June of 2008. In FY 11 staff at the Center continued to invest public funds in strategic opportunities to deliver on the promise of the Life Sciences Initiative: the promise of job creation and a stronger state economy, the promise of advancing scientific discovery and the commercialization of better and lower-cost treatments, and the promise of reaching the ultimate goal – cures. We also are delivering on the promises inherent in innovative public-private partnerships, a strengthened life sciences community and Massachusetts’ position of global life sciences leadership. This report and the accompanying FY 11 Audit Report are submitted in fulfillment of the requirements mandated by the General Court pursuant to the Center’s enabling statute at Mass.
    [Show full text]
  • To View a PDF Copy of the Book 100 Years of Biochemistry at Uoft
    100 Years of Biochemistry at the University of Toronto 1908 - 2008 An Illustrated History by Marian A. Packham University Professor Emeritus ii 100 YEARS OF BIOCHEMISTRY AT U OF T 1908-2008 MARIAN A. PACKHAM arian Packham is one of the world's leading authorities on the biochem istry and Mphysiology of blood platelets, publishing close to 300 papers and is credited with major contriburions to the understanding of plarelets and their role in heart attacks and strokes. She received her B.A. in Biochemistry from the University of Toronto in 1949 and her Ph.D. in 1954 under the supervision of Gordon Butler. From 1955 to 1963 she was a Part-time Senior Fellow/Lecturer in the Department. Prof Packham re-joined the Department in 1966 as a Lecturer. She is a University Professor Emeritus and a Fellow of the Royal Society of Canada. Prof Packham is also the official historian of the Department of Biochemistry. Marian Packham with biography orRosalind Franklin • 100 YEARS OF BIOCHEMISTRY AT U OF T 1908-2008 Printed in Canada by University of Toronto Press 200S ISBN 97S-0-7727 -1700-9 Library and Archives Canada Cataloguing in Publication Packham, Marian A. (Marian Aitchison), 1927- 100 years of biochemistry at the University of Toronto, 1905-200S : an illustrated history / by Marian A. Packham. ISBN 97S-0-7727-1700-9 1. University of Toronto. Dept. of Biochemistry--History. I. University of Toronto. Dept. of Biochemistry II. Title. III. Title: One hundred years of biochemistry at the University of Toronto, 1905-200S. QP511.5.C3P33200S 572'.0711713541
    [Show full text]
  • July 25Th, 2019 Amherst, MA
    2nd Advancing Mass Spectrometry for Biophysics and Structural Biology Meeting July 21st – July 25th, 2019 Amherst, MA Organizer: Richard W. Vachet, University of Massachusetts Amherst AMS Board Peter Armentrout Matthew Bush Valérie Gabelica University of Utah University of Washington Univ. Bordeaux/CNRS/INSERM Rebecca Jockusch Ryan Julian Igor Kaltashov University of Toronto UC Riverside UMass Amherst Nicholas Polfer Mary Rodgers Brandon Ruotolo University of Florida Wayne State University University of Michigan Ryan Steele University of Utah Table of Contents Conference Sponsors………………………………………………………………………………………………………………….……….3 Keynote Speakers……………..…………………………………………………………………………………………………………………4 Student Travel Award Winners…………………………………………………………………………………………………………….6 Map……….……………………………………………………………………………………………………………………………………………7 Getting Around Amherst……………………………………………………………………………………………………………………..8 WiFi Instructions …………………………………………………………………………………………………..…………………………….9 Program Schedule………………………………………………………………………………………..……………………………………10 Poster List………………………………………………………………………………………………………………………………………….17 Abstracts…………………………………………………………………………………………………………………………………………..24 Directory of Participants…………………………………………………………………………………………………………………...85 For more information see https://advancingms.org/ 2 Platinum Sponsor Silver Sponsors Special Thanks 3 Keynote Speakers Professor Michael T. Bowers is a Distinguished Professor in the Department of Chemistry and Biochemistry at the University of California Santa Barbara. He obtained his B.S. from Gonzaga University
    [Show full text]